Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and current operating status. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:26:05.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    UI/metadata updates include adding glossary display, melanoma as a related topic, MedlinePlus Genetics, and a new revision tag (v3.4.0), replacing older QC-related labels. The old labels Last Update Submitted that met QC Criteria, No FEAR Act data, and v3.3.4 were removed.
    Difference
    0.4%
    Check dated 2026-01-28T05:56:11.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows a revision banner updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:49:48.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics. These metadata updates enhance discoverability and context without altering the study content or eligibility criteria.
    Difference
    0.2%
    Check dated 2026-01-07T01:59:54.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Removed related topics links for Melanoma and MedlinePlus Genetics; these are supplementary resources and do not alter the main study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-30T23:44:03.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Locations section now includes New York, and the prior New York Locations listing was removed. This affects where the study is offered and where potential participants should look for site information, with the revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:42:48.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.